NANNETTI, GIULIO
 Distribuzione geografica
Continente #
NA - Nord America 1.686
EU - Europa 223
AS - Asia 125
SA - Sud America 3
AF - Africa 1
Totale 2.038
Nazione #
US - Stati Uniti d'America 1.684
CN - Cina 103
IT - Italia 97
FI - Finlandia 31
DE - Germania 24
SE - Svezia 22
GB - Regno Unito 16
IN - India 10
FR - Francia 9
IE - Irlanda 7
VN - Vietnam 6
UA - Ucraina 5
KR - Corea 3
CA - Canada 2
LU - Lussemburgo 2
PT - Portogallo 2
AT - Austria 1
BO - Bolivia 1
BR - Brasile 1
CL - Cile 1
DK - Danimarca 1
ES - Italia 1
IL - Israele 1
LI - Liechtenstein 1
MA - Marocco 1
MO - Macao, regione amministrativa speciale della Cina 1
NL - Olanda 1
PL - Polonia 1
RO - Romania 1
RU - Federazione Russa 1
TW - Taiwan 1
Totale 2.038
Città #
Fairfield 320
Woodbridge 155
Ann Arbor 151
Ashburn 150
Houston 150
Chandler 140
Seattle 120
Cambridge 113
Wilmington 101
San Diego 29
Helsinki 22
Padova 21
Beijing 19
Boardman 18
Medford 18
Princeton 18
Des Moines 16
Roxbury 13
Columbus 12
Guangzhou 10
Nanjing 9
Pune 9
Dearborn 8
Shanghai 8
Dublin 7
Cagliari 6
Dong Ket 5
Kharkiv 5
Perugia 4
Rome 4
Vicenza 4
Cardiff 3
Florence 3
Hebei 3
Hefei 3
Kunming 3
Nanchang 3
Nürnberg 3
Shenyang 3
Siena 3
Turin 3
Edinburgh 2
Kilburn 2
London 2
Luxembourg 2
Mantova 2
New York 2
Parma 2
Taiyuan 2
Verona 2
Zhengzhou 2
Abano Terme 1
Aprilia 1
Berlin 1
Borås 1
Boston 1
Bucharest 1
Buffalo 1
Changsha 1
Chengdu 1
Chiswick 1
Cochabamba 1
Copenhagen 1
Desio 1
Figline Valdarno 1
Frankfurt am Main 1
Gunzenhausen 1
Hangzhou 1
Hanoi 1
Islington 1
Jiaxing 1
Jinan 1
Langfang 1
Las Vegas 1
Lisbon 1
Luoyang 1
Madrid 1
Manchester 1
Miami 1
Miami Beach 1
Milan 1
Munich 1
Pontypridd 1
Portland 1
Quzhou 1
Rabat 1
Reggio Calabria 1
Rockville 1
Salerno 1
San Francisco 1
Santa Clara 1
Santiago 1
Schaan 1
Southwark 1
St Petersburg 1
Strasbourg 1
São Paulo 1
Taipei 1
Taizhou 1
Tappahannock 1
Totale 1.764
Nome #
4,6-Diphenylpyridines as Promising Novel Anti-Influenza Agents Targeting the PA-PB1 Protein-Protein Interaction: Structure-Activity Relationships Exploration with the Aid of Molecular Modeling 183
A Broad anti-influenza hybrid small molecule that potently disrupts the interaction of polymerase acidic protein-basic protein 1 (PA-PB1) subunits 147
Synthesis and biological evaluation of a library of hybrid derivatives as inhibitors of influenza virus PA-PB1 interaction 146
Antiviral strategies against influenza virus: towards new therapeutic approaches. 144
Drug Repurposing Approach Identifies Inhibitors of the Prototypic Viral Transcription Factor IE2 that Block Human Cytomegalovirus Replication 136
Potent and broad-spectrum cycloheptathiophene-3-carboxamide compounds that target the PA-PB1 interaction of influenza virus RNA polymerase and possess a high barrier to drug resistance 130
Daclatasvir plasma level and resistance selection in HIV patients with hepatitis C virus cirrhosis treated with daclatasvir, sofosbuvir, and ribavirin 125
Development and validation of a simple and robust HPLC method with UV detection for quantification of the hepatitis C virus inhibitor daclatasvir in human plasma 124
Development of a simple HPLC-UV method for the determination of the hepatitis C virus inhibitor simeprevir in human plasma 122
Optimization of Small-Molecule Inhibitors of Influenza Virus Polymerase: From Thiophene-3-Carboxamide to Polyamido Scaffolds 115
Structural investigation of cycloheptathiophene-3-carboxamide derivatives targeting influenza virus polymerase assembly. 111
Exploring the cycloheptathiophene-3-carboxamide scaffold to disrupt the interactions of the influenza polymerase subunits and obtain potent anti-influenza activity 109
A sensitive and validated HPLC-UV method for the quantitative determination of the new antifungal drug isavuconazole in human plasma 104
A quantitative LumiFluo assay to test inhibitory compounds blocking p53 degradation induced by human papillomavirus oncoprotein E6 in living cells 97
Sviluppo e caratterizzazione di nuovi inibitori diretti contro la polimerasi dei virus dell'influenza di tipo A e B 95
Efficient and regioselective one-step synthesis of 7-aryl-5-methyl- and 5-aryl-7-methyl-2-amino-[1,2,4]triazolo[1,5-a] pyrimidine derivatives 79
Corrigendum to “Exploring the cycloheptathiophene-3-carboxamide scaffold to disrupt the interactions of the influenza polymerase subunits and obtain potent anti-influenza activity” [Eur. J. Med. Chem. 138 (2017) 128–139] (S0223523417304610) (10.1016/j.ejmech.2017.06.015)) 70
Synthesis and characterization of 1,2,4-triazolo[1,5-a]pyrimidine-2-carboxamide-based compounds targeting the PA-PB1 interface of influenza A virus polymerase 56
Totale 2.093
Categoria #
all - tutte 6.655
article - articoli 6.272
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.927


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019121 0 0 0 0 0 0 0 0 0 0 65 56
2019/2020557 41 15 13 70 71 46 72 65 81 35 37 11
2020/2021292 25 18 12 17 7 15 11 25 50 10 56 46
2021/2022332 8 58 28 29 41 21 18 34 9 11 16 59
2022/2023328 47 41 5 38 63 31 4 33 30 5 25 6
2023/2024209 3 32 26 13 30 22 41 16 3 20 3 0
Totale 2.093